Tenet Healthcare

Business

NVIDIA Scales Back $100 Billion OpenAI Ambition, Pivots to Broader AI Alliance Strategy

NVIDIA has significantly revised its once-floated $100 billion investment plan for OpenAI, opting for a more measured commitment. The strategic shift underscores the chipmaker's focus on business discipline and diversifying its partnerships across the booming AI ecosystem, even as it remains central to OpenAI's operations.

Feb 2, 2026

Beyond Medicare: The $100K+ Annual Health Costs Retirees Often Overlook

While Medicare provides a crucial safety net at 65, significant gaps in coverage for dental, vision, and long-term care can lead to six-figure annual expenses. Proactive planning with HSAs, specialized insurance, and strategic budgeting is essential to protect retirement savings.

Feb 2, 2026

Business

3M's Rocky Road: Analysts Hold Steady Despite Stock Lagging Behind Market Rally

While 3M shares have significantly underperformed the broader market and its industrial peers over the past year, Wall Street maintains a cautiously optimistic stance, betting on the diversified giant's long-term recovery and earnings resilience.

Feb 2, 2026

Business

Barcelona's Biorce Raises $52.5 Million to Fuel Global Expansion of AI-Powered Clinical Trial Platform

Spanish healthtech startup Biorce has closed a substantial Series A round, backed by prominent venture capital and angel investors, to scale its AI-driven clinical trial solution, Aika, internationally amid a tightening regulatory landscape.

Feb 2, 2026

Business

FDA Delays Aquestive's Anaphylm Epinephrine Film, Demands Human Factors Revisions

The FDA has issued a complete response letter for Aquestive Therapeutics' sublingual epinephrine film Anaphylm, citing concerns over packaging and user instructions. The company aims to address the issues and resubmit its application by the third quarter of this year.

Feb 2, 2026

Business

Beyond the Rally: Three Tech Stocks Poised for Growth in a Volatile 2026 Market

As major indices climb, investors are sifting through economic crosscurrents to find resilient tech innovators. We examine three companies—Veracyte, monday.com, and Zeta Global—whose strategic moves and financial momentum position them for potential growth.

Feb 2, 2026

Business

Retail's Favorites: The Top 10 Stocks Held by Robinhood Traders, and Two Standout Picks

An analysis of the most-held stocks on the Robinhood platform reveals where the retail investing crowd is placing its bets, with two tech giants emerging as particularly compelling long-term investments.

Feb 2, 2026

Business

Adobe and Cognizant Forge Deeper Alliance to Power Enterprise Content with AI

Adobe and Cognizant are expanding their strategic partnership to help major corporations integrate generative AI into content creation and customer experience workflows. The move targets regulated, high-growth industries grappling with soaring demand for personalized content, positioning Adobe's tools as enterprise-ready solutions amid investor scrutiny over its stock performance.

Feb 2, 2026

Business

Amazon to Shutter Palm-Srint Payment System in Retail by 2026, Citing Low Adoption

Amazon will discontinue its Amazon One palm-scanning payment and entry technology at retail locations in 2026, marking a retreat from one of its most ambitious physical commerce experiments.

Feb 2, 2026

Business

Abbott Labs: A Dividend King on Sale? Why Long-Term Investors Are Eyeing the Dip

Despite a post-earnings slump and near 52-week lows, Abbott Laboratories' resilient medical device unit, strategic expansion in diabetes care, and a landmark acquisition in cancer diagnostics paint a promising long-term picture for this Dividend Aristocrat.

Feb 2, 2026

Business

Amgen's Q4 Preview: Wall Street's Mixed Signals on the Biotech Giant

As Amgen prepares to report earnings, analysts are divided on the stock's trajectory. While strategic acquisitions and a solid track record fuel optimism, looming competitive pressures and a key pipeline wait temper expectations.

Feb 2, 2026

Business

Beyond the Tech Bro Dream: How Electricians, Librarians, and Roofers Are Redefining Early Retirement

The FIRE movement is no longer the exclusive domain of high-flying tech salaries. A growing community of middle and working-class Americans is proving that strategic frugality and disciplined investing can pave the way to financial independence decades ahead of schedule.

Feb 2, 2026

World

Voters Back Abortion Rights, But Legislative and Legal Hurdles Persist

Despite successful ballot initiatives in several states, the path to securing abortion access remains fraught with legal challenges and legislative pushback, as seen in ongoing battles from Missouri to Arizona.

Feb 2, 2026

Business

Hedge Fund AIGH Capital Exits Entire MaxLinear Stake in $17.8 Million Sale

AIGH Capital Management has liquidated its entire position in semiconductor firm MaxLinear, a move that coincides with the chipmaker's recent strong quarterly earnings report, raising questions about the fund's strategy.

Feb 2, 2026

Business

France Slaps Uber with $2 Billion Tax Bill in Landmark Gig Economy Clash

French authorities have demanded 1.7 billion euros from Uber for unpaid payroll taxes, alleging the ride-hailing giant misclassified drivers as independent contractors to avoid employer obligations, a report reveals.

Feb 2, 2026

World

Rafah Crossing Reopens: Critically Injured Gazan Evacuated to Egypt for Urgent Treatment

Egypt reopened the Rafah border crossing on Tuesday, allowing the first medical evacuation from Gaza since its latest closure. A critically wounded Palestinian patient was transferred to an Egyptian hospital, amid ongoing hostilities in the Strip.

Feb 2, 2026

Business

The Inflation Mismatch: Why Social Security's Annual Raise Falls Short for Millions of Seniors

While October's COLA announcement brings temporary relief, a growing body of evidence suggests the formula used to calculate Social Security adjustments fails to reflect the real-world expenses of retirees, creating a persistent and compounding budget gap.

Feb 2, 2026

Business

Immunocore's Deep Discount: A Value Trap or a Hidden Gem in Biotech?

After years of share price weakness, Immunocore Holdings (IMCR) appears significantly undervalued by traditional metrics. But does the market know something the models don't? We examine the DCF and P/S analyses, the company's unique T-cell receptor platform, and the risks that have kept investors wary.

Feb 2, 2026

Business

Scholar Rock's Soaring Stock: Is the Biotech's Momentum Justified or Overheated?

Shares of clinical-stage biotech Scholar Rock (NASDAQ: SRRK) have surged nearly 60% in three months, closing at $44.34. This rally, backed by promising clinical progress, has investors weighing its premium valuation against its long-term potential in treating serious diseases.

Feb 2, 2026

Business

Beyond the 9-to-5: Four Remote Side Hustles Poised to Deliver Steady Income in 2026

As economic pressures mount, flexible remote work opportunities are evolving. We examine four proven side gigs that experts project can still generate significant weekly earnings from home in the coming years.

Feb 2, 2026